CP - ceruloplasmin Gene
Species: Sus scrofa
Gene Type: protein coding
Gene ID: 406870
CP Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_001267694.2 | NP_001254623.2 | ceruloplasmin precursor |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
ceruloplasmin |
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(38)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-40354 | Tofacitinib | 99.99% | Yes | |
| HY-50896 | Erlotinib | 99.99% | Yes | |
| HY-14275 | Verapamil | 99.96% | Yes | |
| HY-A0064 | Verapamil hydrochloride | 99.98% | Yes | |
| HY-17506 | Azithromycin | Inhibitor | 98.0% | Yes |
| HY-40354A | Tofacitinib citrate | 99.94% | Yes | |
| HY-B0334 | Sulbactam | Inhibitor | 99.97% | Unkown |
| HY-12008 | Erlotinib Hydrochloride | 99.94% | Yes | |
| HY-10019 | Varenicline | Agonist | 99.92% | Yes |
| HY-B0253 | Piroxicam | Inhibitor | 99.78% | Unkown |
| HY-14542 | Ziprasidone | Antagonist | 99.31% | Unkown |
| HY-10021 | Varenicline Tartrate | 99.96% | Yes | |
| HY-B0210A | Cefoperazone sodium salt | Inhibitor | 99.55% | Yes |
| HY-A0037 | Lasofoxifene | 99.27% | Unkown | |
| HY-B0334A | Sulbactam sodium | Inhibitor | 99.66% | Unkown |
| HY-A0038 | Lasofoxifene tartrate | Modulator | 99.93% | Unkown |
| HY-B0254 | Glipizide | Inhibitor | 99.83% | Unkown |
| HY-13538 | Gemcitabine elaidate | 98.90% | Unkown | |
| HY-10020 | Varenicline Hydrochloride | Agonist | 99.94% | Yes |
| HY-17506A | Azithromycin hydrate | Inhibitor | 98.0% | Yes |
| HY-17484 | Ampiroxicam | 98.73% | Unkown | |
| HY-13010 | Laquinimod | 99.46% | Yes | |
| HY-17407 | Ziprasidone hydrochloride monohydrate | Antagonist | 98.11% | Unkown |
| HY-14542A | Ziprasidone hydrochloride | Antagonist | 99.74% | Unkown |
| HY-B0915 | Orbifloxacin | Inhibitor | 99.66% | Unkown |
| HY-A0064R | Verapamil hydrochloride (Standard) | 99.81% | Unkown | |
| HY-108880 | Carindacillin sodium | Inhibitor | 98.39% | Unkown |
| HY-B0210AR | Cefoperazone sodium salt (Standard) | Inhibitor | 99.07% | Unkown |
| HY-10019A | Varenicline dihydrochloride | Agonist | 98.85% | Yes |
| HY-14275R | Verapamil (Standard) | 99.72% | Unkown | |
| HY-108288 | Sulbactam pivoxil | Inhibitor | 98.0% | Unkown |
| HY-B0501 | Danofloxacin mesylate | Inhibitor | 99.88% | Unkown |
| HY-14542B | Ziprasidone mesylate trihydrate | Antagonist | / | Unkown |
| HY-108288R | Sulbactam pivoxil (Standard) | Inhibitor | / | Unkown |
| HY-14542C | Ziprasidone mesylate | Antagonist | / | Unkown |
| HY-12008A | Erlotinib mesylate | / | Unkown | |
| HY-17484R | Ampiroxicam (Standard) | / | Unkown | |
| HY-B0915R | Orbifloxacin (Standard) | Inhibitor | / | Unkown |
Inhibitory Antibodies
(2)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P9918 | Tremelimumab | 99.50% | Unkown | |
| HY-P99965 | Crovalimab | Inhibitor | 99.59% | Unkown |
Clinical Phase
Bioactive Molecules
(36)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase
|
|---|---|---|---|---|
| HY-N0678 | Icaritin | Inducer | 99.06% | Phase 4 |
| HY-124498 | Oxantel | Inhibitor | / | Phase 4 |
| HY-10211 | Tanespimycin | 99.01% | Phase 3 | |
| HY-13223 | Crenolanib | 99.68% | Phase 3 | |
| HY-10871 | Otenabant | Antagonist | 99.63% | Phase 3 |
| HY-12089 | Torcetrapib | Inhibitor | 99.82% | Phase 3 |
| HY-105284 | Sulopenem | Inhibitor | 99.16% | Phase 3 |
| HY-105028 | Tenidap | 99.93% | Phase 3 | |
| HY-14941 | Elacytarabine | ≥98.0% | Phase 3 | |
| HY-10871A | Otenabant Hydrochloride | Antagonist | / | Phase 3 |
| HY-W062904 | Laquinimod sodium | Inhibitor | / | Phase 3 |
| HY-105086 | Pamaqueside | Inhibitor | / | Phase 3 |
| HY-105284A | Sulopenem sodium | Inhibitor | / | Phase 3 |
| HY-P1717A | AMY-101 TFA | Inhibitor | 99.92% | Phase 2 |
| HY-W018061 | Traxoprodil | Antagonist | 99.92% | Phase 2 |
| HY-14674 | CP-724714 | 98.72% | Phase 2 | |
| HY-14839 | Evatanepag | Agonist | 98.58% | Phase 2 |
| HY-13302 | CP-547632 | Inhibitor | 99.94% | Phase 2 |
| HY-19687 | Zopolrestat | Inhibitor | 99.92% | Phase 2 |
| HY-13302B | CP-547632 hydrochloride | Inhibitor | 99.79% | Phase 2 |
| HY-13538A | Gemcitabine elaidate hydrochloride | 97.39% | Phase 2 | |
| HY-10049 | CP 122721 | Antagonist | / | Phase 2 |
| HY-105192 | CP-122288 | Agonist | / | Phase 2 |
| HY-106106 | Tiqueside | Inhibitor | / | Phase 2 |
| HY-120057 | CP-331684 | Agonist | / | Phase 2 |
| HY-14129 | CP 316311 | Antagonist | / | Phase 2 |
| HY-149769 | CP-506 | Substrate | / | Phase 2 |
| HY-16372 | CP 461 | / | Phase 2 | |
| HY-P1717 | AMY-101 | Inhibitor | 99.86% | Phase 1 |
| HY-19193 | CP-105696 | Antagonist | 99.93% | Phase 1 |
| HY-16373 | CP-609754 | Inhibitor | 99.49% | Phase 1 |
| HY-12946 | BI 653048 | Inhibitor | 99.84% | Phase 1 |
| HY-13223A | Crenolanib benzenesulfonate | 99.45% | Phase 1 | |
| HY-105316 | CP-800569 | Inhibitor | / | Phase 1 |
| HY-12946A | BI 653048 phosphate | Inhibitor | / | Phase 1 |
| HY-U00401 | (Rac)-CP-609754 | Inhibitor | / | Phase 1 |
Inhibitory Antibodies
(2)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase
|
|---|---|---|---|---|
| HY-P99197 | Figitumumab | Inhibitor | ≥99.0% | Phase 3 |
| HY-P99046 | Selicrelumab | Agonist | 99.29% | Phase 2 |
Pre-clinical Phase
Bioactive Molecules
(309)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-12815 | MCC950 | Inhibitor | 99.78% | Unkown |
| HY-12815A | MCC950 sodium | Inhibitor | 99.75% | Unkown |
| HY-B1368 | Fenclonine | Inhibitor | 99.98% | Unkown |
| HY-12050 | CP-673451 | Inhibitor | 99.65% | Unkown |
| HY-13525 | CP-91149 | 99.84% | Unkown | |
| HY-108347 | CP-100356 hydrochloride | Inhibitor | 99.68% | Unkown |
| HY-112136 | TAO Kinase inhibitor 1 | 99.81% | Unkown | |
| HY-108615 | CP-316819 | Inhibitor | 99.0% | Unkown |
| HY-P1717B | AMY-101 acetate | Inhibitor | 99.93% | Unkown |
| HY-N0245 | Theaflavin-3-gallate | Inducer | 99.89% | Unkown |
| HY-103068 | Diethyl-pythiDC | 99.90% | Unkown | |
| HY-115319 | CP-24879 hydrochloride | 99.59% | Unkown | |
| HY-W019734 | [Rh(Cp-)Cl2]2 | 98.20% | Unkown | |
| HY-100207 | CP21R7 | Inhibitor | 99.74% | Unkown |
| HY-12506 | Naspm | Inhibitor | 96.30% | Unkown |
| HY-139330 | MGH-CP1 | Inducer | 99.56% | Unkown |
| HY-49116 | CP26 | Inhibitor | 98.19% | Unkown |
| HY-B1161A | S-Methoprene | Antagonist | 98.58% | Unkown |
| HY-12506A | Naspm trihydrochloride | Inhibitor | 98.50% | Unkown |
| HY-15662 | Tulathromycin A | Inhibitor | 98.0% | Unkown |
| HY-W018845 | [Ir(Cp-)Cl2]2 | ≥99.0% | Unkown | |
| HY-15259 | CP-640186 | Inhibitor | 99.21% | Unkown |
| HY-113421 | Linoleoyl ethanolamide | 99.98% | Unkown | |
| HY-18343A | CP-31398 dihydrochloride | p53 Activator | 99.63% | Unkown |
| HY-103151 | CP94253 hydrochloride | Agonist | 98.00% | Unkown |
| HY-123772 | CDK5 inhibitor 20-223 | Inhibitor | 99.62% | Unkown |
| HY-12129 | CP 154526 hydrochloride | Antagonist | 99.76% | Unkown |
| HY-W187279 | Karrikin 2 | 99.17% | Unkown | |
| HY-125835 | CP-10 | Inhibitor | 98.41% | Unkown |
| HY-130257 | CP5V | 99.31% | Unkown | |
| HY-15259A | CP-640186 hydrochloride | Inhibitor | 99.65% | Unkown |
| HY-113955 | CP-346086 | 99.18% | Unkown | |
| HY-15243 | Capromorelin Tartrate | Agonist | 98.10% | Unkown |
| HY-14899 | Taprenepag | Agonist | 98.79% | Unkown |
| HY-19396 | Ingliforib | Inhibitor | 99.07% | Unkown |
| HY-11002 | CP-466722 | Inhibitor | 99.74% | Unkown |
| HY-124815 | CP-312 | Inducer | 99.18% | Unkown |
| HY-14130 | CP 376395 | Antagonist | 99.59% | Unkown |
| HY-150082 | CP681301 | Inhibitor | 99.18% | Unkown |
| HY-125843 | Pomalidomide-PEG1-C2-N3 | 99.91% | Unkown | |
| HY-105064D | Zoniporide hydrochloride hydrate | Inhibitor | 99.16% | Unkown |
| HY-17506S | Azithromycin-d3 | Inhibitor | 99.7% | Unkown |
| HY-103070 | PythiDC | Inhibitor | 99.05% | Unkown |
| HY-15543A | CP-809101 hydrochloride | Agonist | 98.61% | Unkown |
| HY-A0064S | Verapamil-d3 hydrochloride | 99.57% | Unkown | |
| HY-101357A | CP 93129 dihydrochloride | Agonist | 98.01% | Unkown |
| HY-108571 | CP-775146 | Agonist | 98.70% | Unkown |
| HY-120160 | Darglitazone | Agonist | 99.19% | Unkown |
| HY-19360 | Sulprostone | Agonist | ≥99.0% | Unkown |
| HY-105445 | CP-113818 | Inhibitor | 99.70% | Unkown |
| HY-A0104C | HPMC (Type I,Viscosity:400mPa.s) | / | Unkown | |
| HY-108574 | CP 339818 hydrochloride | Inhibitor | 99.61% | Unkown |
| HY-130296 | Palbociclib-propargyl | 96.12% | Unkown | |
| HY-130841 | Apcin-A | Inhibitor | 98.0% | Unkown |
| HY-13256 | Desmethyl Erlotinib hydrochloride | 99.23% | Unkown | |
| HY-136951 | cp028 | Inhibitor | 99.71% | Unkown |
| HY-164605 | (6S)-CP-470711 | Inhibitor | 98.75% | Unkown |
| HY-18663 | CP-465022 | Antagonist | 98.24% | Unkown |
| HY-40354S | Tofacitinib-13C3 | 99.77% | Unkown | |
| HY-116530 | 9-Cyclopentyladenine monomethanesulfonate | Inhibitor | 99.95% | Unkown |
| HY-116893 | Diethyl bipy55'DC | Inhibitor | 98.79% | Unkown |
| HY-119721 | CP-424174 | Inhibitor | 98.69% | Unkown |
| HY-12095 | CB1 inverse agonist 2 | Agonist | 99.15% | Unkown |
| HY-W011085 | CP-471474 | Inhibitor | 99.2% | Unkown |
| HY-105064 | Zoniporide | Inhibitor | 99.89% | Unkown |
| HY-130452 | NOS1-IN-1 | Inhibitor | 95.0% | Unkown |
| HY-101803 | CP671305 | Inhibitor | 99.95% | Unkown |
| HY-107634 | CP-20961 | Inducer | 98.34% | Unkown |
| HY-116006 | Bis-PEG5-acid | 99.90% | Unkown | |
| HY-116699 | CP-868388 free base | Agonist | 99.66% | Unkown |
| HY-118140 | ZCZ011 | Modulator | 99.68% | Unkown |
| HY-179055 | PROTAC DAPK1 Degrader-1 | Degrader | 96.70% | Unkown |
| HY-40354AS | Tofacitinib-d3 citrate | 99.59% | Unkown | |
| HY-113421S | Linoleoyl ethanolamide-d4 | 99.2% | Unkown | |
| HY-13340 | VU0152100 | Modulator | 98.98% | Unkown |
| HY-107213 | Tulathromycin B | Inhibitor | / | Unkown |
| HY-108482 | CP-96,345 | Inhibitor | 99.9% | Unkown |
| HY-108623 | Atizoram | Inhibitor | 96.3% | Unkown |
| HY-116082 | CP 226269 | Agonist | 99.65% | Unkown |
| HY-13256A | Desmethyl Erlotinib | 98.77% | Unkown | |
| HY-136608 | 5-AAM-2-CP | Agonist | 99.22% | Unkown |
| HY-136609 | 5-AMAM-2-CP | Agonist | 98.21% | Unkown |
| HY-50896S | Erlotinib-d6 | 99.84% | Unkown | |
| HY-B0254S | Glipizide-d11 | Inhibitor | 96.36% | Unkown |
| HY-P11174 | CP05 | Ligand | 97.10% | Unkown |
| HY-W018061C | (R,R)-Traxoprodil | Antagonist | 99.00% | Unkown |
| HY-W772850 | Fenclonine hydrochloride | Inhibitor | 98.60% | Unkown |
| HY-118639 | CP-74006 | Inhibitor | 98.86% | Unkown |
| HY-149769A | CP-506 mesylate | Substrate | 98.59% | Unkown |
| HY-160901 | CP-289,503 | Inhibitor | 98.21% | Unkown |
| HY-17506S1 | Azithromycin-13C,d3 | 99.90% | Unkown | |
| HY-131959 | (S,R,S)-AHPC-PEG5-Boc | / | Unkown | |
| HY-112199 | CP-447697 | Antagonist | 99.70% | Unkown |
| HY-112742 | CP-195543 | Antagonist | 98.86% | Unkown |
| HY-12008S | Erlotinib-d6 hydrochloride | 98.13% | Unkown | |
| HY-121755 | Tibric acid | Agonist | / | Unkown |
| HY-123039 | CP-532623 | Inhibitor | ≥99.0% | Unkown |
| HY-13302C | CP-547632 TFA | Inhibitor | 99.42% | Unkown |
| HY-138879 | CP-601927 | Agonist | 98.24% | Unkown |
| HY-138879A | (Rac)-CP-601927 hydrochloride | Agonist | 99.72% | Unkown |
| HY-138879B | CP-601932 | Agonist | 99.74% | Unkown |
| HY-15541 | Zaltidine | Antagonist | 99.49% | Unkown |
| HY-163101 | CP-96021 | Antagonist | 98.04% | Unkown |
| HY-164749 | K-Ras-IN-4 | Inhibitor | / | Unkown |
| HY-172018 | CP-LC-0729 | 99.92% | Unkown | |
| HY-B0253S | Piroxicam-d3 | Inhibitor | 99.68% | Unkown |
| HY-U00070 | Dirlotapide | 99.86% | Unkown | |
| HY-W654064 | Azithromycin-13C,d3-1 | 99.9% | Unkown | |
| HY-101639 | CP-409092 | Agonist | / | Unkown |
| HY-129795 | Thiazolylalanine | / | Unkown | |
| HY-13010S | Laquinimod-d5 | Inhibitor | 98.25% | Unkown |
| HY-13223R | Crenolanib (Standard) | 98.12% | Unkown | |
| HY-177596A | Dicytidine 5′-triphosphate trisodium | Activator | / | Unkown |
| HY-B0334AS | Sulbactam-d5 sodium | Inhibitor | 99.90% | Unkown |
| HY-U00004 | OSIP-486823 | Inhibitor | 98.0% | Unkown |
| HY-119236 | CP-432 | / | Unkown | |
| HY-10019AS1 | Varenicline-d4 hydrochloride | Agonist | / | Unkown |
| HY-10019S | Varenicline-d4 | Agonist | / | Unkown |
| HY-10019S1 | Varenicline-15N,13C,d2 | Agonist | / | Unkown |
| HY-10020S | Varenicline-15N3 hydrochloride | Agonist | / | Unkown |
| HY-100280 | Pirolate | Antagonist | / | Unkown |
| HY-100332 | CP 375 | / | Unkown | |
| HY-10049A | CP 122721 hydrochloride | Antagonist | / | Unkown |
| HY-101357 | CP 93129 | Agonist | / | Unkown |
| HY-101558 | Elzasonan | Antagonist | / | Unkown |
| HY-101558A | Elzasonan citrate | Antagonist | / | Unkown |
| HY-101558B | Elzasonan hydrochloride | Antagonist | / | Unkown |
| HY-10211S | Tanespimycin-d5 | / | Unkown | |
| HY-103092 | CP-135807 | Agonist | / | Unkown |
| HY-103151A | CP94253 | Agonist | / | Unkown |
| HY-103379 | CP 376395 hydrochloride | Antagonist | / | Unkown |
| HY-105028S | Tenidap-d3 | Inhibitor | / | Unkown |
| HY-105064A | Zoniporide mesylate | Inhibitor | / | Unkown |
| HY-105064B | Zoniporide hydrochloride | Inhibitor | / | Unkown |
| HY-105064C | Zoniporide dihydrochloride | Inhibitor | / | Unkown |
| HY-105157 | Icopezil | Inhibitor | / | Unkown |
| HY-105205 | Terlakiren | Inhibitor | / | Unkown |
| HY-105358 | CP-288886 | Antagonist | / | Unkown |
| HY-105434 | CP-74667 | Inhibitor | / | Unkown |
| HY-106493 | Tametraline | Inhibitor | / | Unkown |
| HY-107013 | CP-544439 | Inhibitor | / | Unkown |
| HY-107233 | Saponin CP4 | / | Unkown | |
| HY-107235 | Saponin CP6 | / | Unkown | |
| HY-108347A | CP-100356 | Inhibitor | / | Unkown |
| HY-109855 | CP-67015 | Inhibitor | / | Unkown |
| HY-113642 | CP-67804 | / | Unkown | |
| HY-113955A | CP-346086 dihydrate | / | Unkown | |
| HY-114540 | CP-339818 | Inhibitor | / | Unkown |
| HY-116142 | CP-283097 | Antagonist | / | Unkown |
| HY-117172 | CP320626 | Inhibitor | / | Unkown |
| HY-117641 | CP 81282 | Inhibitor | / | Unkown |
| HY-117803 | CP 461 free base | / | Unkown | |
| HY-117868 | NC-174 | / | Unkown | |
| HY-118056 | ABD459 | Antagonist | / | Unkown |
| HY-118625 | CP-457920 | Inhibitor | / | Unkown |
| HY-118842 | Sunepitron hydrochloride | / | Unkown | |
| HY-118900 | CP-654577 | / | Unkown | |
| HY-119058 | ARI-809 | Inhibitor | / | Unkown |
| HY-119080 | CP8754 | Antagonist | / | Unkown |
| HY-119142 | CP-664511 | Antagonist | / | Unkown |
| HY-120076 | CP-293019 | Antagonist | / | Unkown |
| HY-12008S1 | Erlotinib-13C6 hydrochloride | / | Unkown | |
| HY-120093 | GAT100 | / | Unkown | |
| HY-120160A | Darglitazone Sodium | Agonist | / | Unkown |
| HY-12079 | CP-481715 | Antagonist | / | Unkown |
| HY-121293 | CP-944629 | Inhibitor | / | Unkown |
| HY-12130 | CP 154526 | Antagonist | / | Unkown |
| HY-12144 | CP-99994 | / | Unkown | |
| HY-12145 | CP-99994 hydrochloride | Inhibitor | / | Unkown |
| HY-121866 | CP-84364 | Inhibitor | / | Unkown |
| HY-122109A | Levonantradol hydrochloride | Agonist | / | Unkown |
| HY-122118 | Lambast | / | Unkown | |
| HY-122483 | Diethyl pyimDC | Inhibitor | / | Unkown |
| HY-123139 | Flutroline | / | Unkown | |
| HY-123203 | CP-608039 | Agonist | / | Unkown |
| HY-124336 | CP 80080 | Ligand | / | Unkown |
| HY-125627 | CP-394531 | Antagonist | / | Unkown |
| HY-130205 | Milacemide hydrochloride | Inhibitor | / | Unkown |
| HY-13256AS1 | Desmethyl Erlotinib-d4-1 | / | Unkown | |
| HY-135254 | CP-46665 dihydrochloride | Inhibitor | / | Unkown |
| HY-137607A | UMP-CP trisodium | Agonist | / | Unkown |
| HY-14275S1 | Verapamil-d7 | / | Unkown | |
| HY-14411 | JNK-1-IN-1 | Inhibitor | / | Unkown |
| HY-145126 | CP-628006 | Activator | / | Unkown |
| HY-14542S | Ziprasidone-d8 | Antagonist | / | Unkown |
| HY-145743 | CP-17 | Inhibitor | / | Unkown |
| HY-146815 | CP19 | / | Unkown | |
| HY-14839A | Evatanepag sodium | Agonist | / | Unkown |
| HY-149495 | CP-07 | Degrader | / | Unkown |
| HY-150665S | N-Dansyl-d6 1,4-diaminobutane, 97% (CP) | / | Unkown | |
| HY-151267 | SARS-CoV-2-IN-25 | Inhibitor | / | Unkown |
| HY-151267A | SARS-CoV-2-IN-25 disodium | Inhibitor | / | Unkown |
| HY-15242 | Capromorelin | Activator | / | Unkown |
| HY-155044 | TMV-IN-5 | Inhibitor | / | Unkown |
| HY-155045 | TMV-IN-6 | Inhibitor | / | Unkown |
| HY-15541A | Zaltidine dihydrochloride | Antagonist | / | Unkown |
| HY-15662S | Tulathromycin A-d7 | Inhibitor | / | Unkown |
| HY-162807 | TMV-IN-10 | Inhibitor | / | Unkown |
| HY-164698 | CP-470711 | Inhibitor | / | Unkown |
| HY-165444 | CP-615003 | Agonist | / | Unkown |
| HY-167946 | CP-866087 | Antagonist | / | Unkown |
| HY-168971 | Paeoniflorin-6′-O-benzene sulfonate | / | Unkown | |
| HY-169232 | PCC16 chloride | / | Unkown | |
| HY-16946 | CP-610431 | Inhibitor | / | Unkown |
| HY-171113 | CP-LC-1074 | / | Unkown | |
| HY-172015 | CP-LC-1143 | / | Unkown | |
| HY-172016 | CP-LC-0867 | / | Unkown | |
| HY-172017 | CP-LC-1254 | / | Unkown | |
| HY-174335 | UVI3502 | Antagonist | / | Unkown |
| HY-175233 | Mesotrypsin IN-1 | / | Unkown | |
| HY-176027 | CP-LC-1422 | / | Unkown | |
| HY-176751 | TG-2-IN-5 | Inhibitor | / | Unkown |
| HY-18228 | CP-352664 | Inhibitor | / | Unkown |
| HY-182301 | CP 71362 | Inhibitor | / | Unkown |
| HY-18343 | CP-31398 | p53 Activator | / | Unkown |
| HY-185643 | PF-04475270 | Agonist | / | Unkown |
| HY-18663A | CP-465022 maleate | Antagonist | / | Unkown |
| HY-18663B | CP-465022 hydrochloride | Antagonist | / | Unkown |
| HY-19048 | CP-66948 | Antagonist | / | Unkown |
| HY-19241 | CP-85958 | Antagonist | / | Unkown |
| HY-19277 | CP-114271 | Agonist | / | Unkown |
| HY-19454 | CP-464709 | Agonist | / | Unkown |
| HY-40354S1 | Tofacitinib-13C3,15N | 99.57% | Unkown | |
| HY-50896S1 | Erlotinib-13C6 | / | Unkown | |
| HY-A0064S1 | Verapamil-d6 hydrochloride | / | Unkown | |
| HY-B0253S1 | Piroxicam-d4 | Inhibitor | / | Unkown |
| HY-B0334AS1 | Sulbactam-d2 sodium | / | Unkown | |
| HY-B0501S | Danofloxacin-d3 mesylate | Inhibitor | / | Unkown |
| HY-B0915S | Orbifloxacin-d5 hydrochloride | Inhibitor | / | Unkown |
| HY-D1346 | 610CP | / | Unkown | |
| HY-D1418 | CP-BP-SFAC | / | Unkown | |
| HY-D3189 | 5GluAF-2MeTG | / | Unkown | |
| HY-N0245R | Theaflavin-3-gallate (Standard) | Inducer | / | Unkown |
| HY-N10268 | 3-Hydroxyterphenyllin | / | Unkown | |
| HY-N16303 | CP-LC-1421 | / | Unkown | |
| HY-N16318 | CP-LC-1067 | / | Unkown | |
| HY-P10384 | SPSB2-iNOS inhibitory cyclic peptide-2 | Inhibitor | / | Unkown |
| HY-P10385 | SPSB2-iNOS inhibitory cyclic peptide-3 | / | Unkown | |
| HY-P10828 | MAPI | Inhibitor | / | Unkown |
| HY-P11020 | p27 Analogue CP2 | Inhibitor | / | Unkown |
| HY-P11076 | CP-EPS8-NLS | Inhibitor | / | Unkown |
| HY-P11494 | AWWNTEW | Ligand | / | Unkown |
| HY-P11792 | CP2-CPP | / | Unkown | |
| HY-P1609 | CP-69799 | Inhibitor | / | Unkown |
| HY-P2024 | CP-85339 | Inhibitor | / | Unkown |
| HY-RS03079 | CP Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W008914 | (E/Z)-CP-724714 | Inhibitor | / | Unkown |
| HY-W018061A | Traxoprodil mesylate | Antagonist | / | Unkown |
| HY-W115746A | Ethyl cellulose (viscosity 10 cP) | / | Unkown | |
| HY-W115746B | Ethyl cellulose (viscosity 300 cP) | / | Unkown | |
| HY-W879307 | CP-201 | / | Unkown | |
| HY-10019S2 | Varenicline-13C15N | Agonist | / | Unkown |
| HY-100316 | CP-96486 | Antagonist | / | Unkown |
| HY-101731 | CP-96021 hydrochloride | Antagonist | / | Unkown |
| HY-103151R | CP94253 hydrochloride (Standard) | Agonist | / | Unkown |
| HY-105028A | Tenidap sodium | Inhibitor | / | Unkown |
| HY-10814 | CP-810123 | Agonist | / | Unkown |
| HY-108615R | CP-316819 (Standard) | Inhibitor | / | Unkown |
| HY-111129 | CP-66713 | Antagonist | / | Unkown |
| HY-111159 | CP-467688 | Inhibitor | / | Unkown |
| HY-111211 | CP-457493 | / | Unkown | |
| HY-119879 | Binfloxacin | Inhibitor | / | Unkown |
| HY-122174 | ME-1036 | Inhibitor | / | Unkown |
| HY-122284 | CP-5068 | Inhibitor | / | Unkown |
| HY-123289 | CP-690550A | Inhibitor | / | Unkown |
| HY-123311 | CP59430 | Antagonist | / | Unkown |
| HY-123571 | CP-199330 | Antagonist | / | Unkown |
| HY-123582 | CP-866,087 | / | Unkown | |
| HY-129698 | MS-073 | Inhibitor | / | Unkown |
| HY-129785 | CP-220629 | Inhibitor | / | Unkown |
| HY-129925 | CP-49674 | / | Unkown | |
| HY-14275S | Verapamil-d3 | / | Unkown | |
| HY-14275S2 | Verapamil-d6 | / | Unkown | |
| HY-150346 | 1cP-MiPLA | / | Unkown | |
| HY-15543 | CP-809101 | Agonist | / | Unkown |
| HY-15661A | OSI-413 free base | / | Unkown | |
| HY-163999 | TMV-IN-12 | Inhibitor | / | Unkown |
| HY-165129 | CP102 | / | Unkown | |
| HY-169723 | CP 524515 | Inhibitor | / | Unkown |
| HY-171185 | CP-611,781 | / | Unkown | |
| HY-171476 | CP-865569 | Antagonist | / | Unkown |
| HY-171956 | Carmaphycin-17 | Inhibitor | / | Unkown |
| HY-172014 | CP-LC-0743 | / | Unkown | |
| HY-172059 | 3C-P hydrochloride | / | Unkown | |
| HY-172925 | CP-LC-1447 | / | Unkown | |
| HY-172926 | CP-LC-1428 | / | Unkown | |
| HY-174326 | Antibacterial agent 282 | Inhibitor | / | Unkown |
| HY-177596 | Dicytidine 5′-triphosphate | Activator | / | Unkown |
| HY-180272 | TMV-IN-15 | Inhibitor | / | Unkown |
| HY-184351 | CP 132484 | Agonist | / | Unkown |
| HY-40354S2 | Tofacitinib-13C,d3 | / | Unkown | |
| HY-40354S3 | Tofacitinib-13C | / | Unkown | |
| HY-40354S5 | Tofacitinib-d3 | / | Unkown | |
| HY-50896S2 | Erlotinib-d4 | / | Unkown | |
| HY-50896S3 | Erlotinib-d8 | / | Unkown | |
| HY-B0253A | Piroxicam olamine | Inhibitor | / | Unkown |
| HY-B0334S | Sulbactam-d3 | Inhibitor | / | Unkown |
| HY-N13047 | Ningnanmycin | / | Unkown | |
| HY-P10200 | CP7-FP13-2 | Inhibitor | / | Unkown |
| HY-RS16625 | Cp Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS23060 | Cp Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-U00008 | CP-28888 | Inducer | / | Unkown |
| HY-W020041 | CP 53631 | Inhibitor | / | Unkown |
| HY-W1130407 | CP-LC-1073 | / | Unkown | |
| HY-W614725 | Apcin-A monohydrochloride | Inhibitor | / | Unkown |
| HY-W653875 | Azithromycin-d5 | Inhibitor | / | Unkown |
| HY-W936871 | Hydrouracil-(4-CP) | / | Unkown | |
| HY-U00354 | CP-060 | Antagonist | / | Unkown |
| HY-U00270 | CP-319340free base | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service